Invention Grant
US08951967B2 Recombinant FSH including alpha 2,3- and alpha 2,6-sailylation
有权
重组FSH包括α2,3-和α2,6-甲酰化
- Patent Title: Recombinant FSH including alpha 2,3- and alpha 2,6-sailylation
- Patent Title (中): 重组FSH包括α2,3-和α2,6-甲酰化
-
Application No.: US12988218Application Date: 2009-04-16
-
Publication No.: US08951967B2Publication Date: 2015-02-10
- Inventor: Ian Cottingham , Daniel Plaksin , Richard Boyd White
- Applicant: Ian Cottingham , Daniel Plaksin , Richard Boyd White
- Applicant Address: CH Saint-Prex
- Assignee: Ferring International Center SA
- Current Assignee: Ferring International Center SA
- Current Assignee Address: CH Saint-Prex
- Agency: Fish & Richardson P.C.
- Priority: EP08251528 20080425
- International Application: PCT/GB2009/000978 WO 20090416
- International Announcement: WO2009/127826 WO 20091022
- Main IPC: A61K38/24
- IPC: A61K38/24 ; C07K14/59 ; A61P5/06 ; C12P21/00 ; A61K38/00
Abstract:
The present disclosure describes recombinant follicle stimulating hormone (FSH) and methods for the production thereof. The recombinant FSH can include α2,3, α2,6, and, optionally, α2,8 sialylation. The recombinant FSH can be produced in a human cell line such as a PER.C6® cell line.
Public/Granted literature
- US20110105398A1 RECOMBINANT FSH INCLUDING ALPHA 2,3- AND ALPHA 2,6-SAILYLATIO Public/Granted day:2011-05-05
Information query
IPC分类:
